Uric acid increase and calcium levels decrease
Reading File
Finding Sources
Finding Sources
Searching PubMed
hyperuricemia hypocalcemia
Finding Sources
Finding Sources
Reading File
Reading File
Excellent - I now have comprehensive textbook information. Here is the full, well-sourced answer:
Elevated Uric Acid + Decreased Calcium: Tumor Lysis Syndrome
The classic condition causing hyperuricemia + hypocalcemia together is Tumor Lysis Syndrome (TLS).
What Is TLS?
TLS is a metabolic emergency caused by massive, rapid destruction of tumor cells - either from chemotherapy or (rarely) spontaneously. As cancer cells lyse, their intracellular contents flood the bloodstream simultaneously, producing a characteristic tetrad of electrolyte abnormalities.
The Four Lab Abnormalities (Cairo-Bishop Criteria)
| Finding | Mechanism |
|---|---|
| Hyperuricemia (↑ uric acid) | Cell nuclei contain large amounts of DNA/RNA; purine nucleotides are catabolized to uric acid |
| Hypocalcemia (↓ calcium) | Massive phosphate release from cells (malignant cells contain 4x the normal phosphate load) - phosphate binds calcium and precipitates it |
| Hyperkalemia (↑ potassium) | Intracellular K⁺ released during cell death |
| Hyperphosphatemia (↑ phosphate) | Direct release of intracellular phosphate |
Two or more of the above within 3 days before or 7 days after starting chemotherapy meets laboratory TLS criteria.
Why Uric Acid Rises
Cell DNA and RNA are broken down to purines, which are metabolized to uric acid via xanthine oxidase. In TLS, uric acid can precipitate in renal tubules, causing uric acid nephropathy and acute kidney injury (AKI). This is also why allopurinol or rasburicase is given prophylactically.
Why Calcium Falls
Malignant cells contain roughly 4 times the phosphate of normal cells. When they burst, serum phosphate surges rapidly. Phosphate combines with calcium in the blood (and in renal tubules/parenchyma), forming calcium-phosphate precipitates. The result is:
- Serum calcium drops sharply
- Hypocalcemia causes tetany, seizures, and cardiac dysrhythmias
- Paradoxically, supplemental calcium is generally avoided in TLS unless there is cardiovascular instability or active seizures - because giving calcium when phosphate is already high just worsens metastatic calcium-phosphate precipitation in tissues and kidneys
Classic TLS Triggers
- Highest risk: Burkitt lymphoma, high-grade non-Hodgkin lymphoma, acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML) with very high WBC
- Lower risk (but possible): Solid tumors with large burden (breast, colorectal, lung)
- Spontaneous TLS: Rare; occurs before any treatment in rapidly proliferating tumors
Clinical Consequences
| Problem | Cause |
|---|---|
| Acute kidney injury | Uric acid crystals + calcium-phosphate crystals in renal tubules |
| Cardiac arrhythmia / arrest | Hyperkalemia (most immediately life-threatening) + hypocalcemia |
| Tetany, seizures | Hypocalcemia |
| Sudden death | Combined electrolyte crisis |
Management
- Aggressive IV hydration - cornerstone; increases urine flow to flush urate and phosphate crystals from renal tubules
- Allopurinol - prophylaxis; blocks xanthine oxidase to prevent new uric acid formation
- Rasburicase - breaks down existing uric acid; preferred in high-risk patients
- Phosphate binders - limit further phosphate absorption
- Dextrose + insulin - helps shift K⁺ back into cells and manages phosphate
- Hemodialysis - corrects all abnormalities when renal failure develops or electrolyte burden is overwhelming
- ICU admission with continuous cardiac monitoring
Other Conditions That Can Raise Uric Acid AND Lower Calcium (Less Common)
- Hypoparathyroidism - PTH normally increases renal uric acid excretion; when PTH is absent, uric acid retention can occur alongside the classic hypocalcemia. However, hyperuricemia here is mild and inconsistent.
- Chronic kidney disease - Both uric acid (reduced excretion) and calcium (reduced vitamin D activation) are affected.
- Rhabdomyolysis - Massive muscle breakdown also releases purines and phosphate, similar mechanism to TLS.
The combination as a paired, dramatic, simultaneous finding is most specific for TLS.
Sources: Tintinalli's Emergency Medicine, p. 1558 | Brenner & Rector's The Kidney, p. 1877 | Recent reviews: Tumor lysis syndrome (Nature Reviews Disease Primers, 2024, PMID 39174582); TLS management guidelines (Cancer Treatment Reviews, 2023, PMID 37579533)
This is a shared conversation. Sign in to Orris to start your own chat.